Sub Banner Image

Eli Lilly Launches Flat Pricing For Zepbound, Capping Monthly Cost At $499

Market Impact

Vandana Singh

·

June 16, 2025

·

Benzinga

Eli Lilly expands Zepbound access with flat-rate pricing and new vial options, supporting wider obesity treatment access without insurance barriers.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.